Clusterin in Alzheimer's disease: An amyloidogenic inhibitor of amyloid formation? (bibtex)
by Panagiotis M. Spatharas, Georgia I. Nasi, Paraskevi L. Tsiolaki, Marilena K. Theodoropoulou, Nikos C. Papandreou, Andreas Hoenger, Ioannis P. Trougakos and Vassiliki A. Iconomidou
Reference:
Clusterin in Alzheimer's disease: An amyloidogenic inhibitor of amyloid formation? (Panagiotis M. Spatharas, Georgia I. Nasi, Paraskevi L. Tsiolaki, Marilena K. Theodoropoulou, Nikos C. Papandreou, Andreas Hoenger, Ioannis P. Trougakos and Vassiliki A. Iconomidou), In Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, volume 1868, 2022.
Bibtex Entry:
@article{doi:0.1016/j.bbadis.2022.166384,
        call={pr007},
        acronym={AbetaDynamics},
        fulltitle={Structural and Computational Studies of Amyloid β Aggregation in Alzheimer’s disease },
        pi={VassilikiIconomidou },
        affiliation={National and Kapodistrian University of Athens},
        researchfield={Biochemistry, Bioinformatics and Life sciences },
	title = {Clusterin in Alzheimer's disease: An amyloidogenic inhibitor of amyloid formation?},
	journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
	volume = {1868},
	number = {7},
	pages = {166384},
	year = {2022},
	bibyear = {2022},
	issn = {0925-4439},
	doi = {0.1016/j.bbadis.2022.166384},
	url = {https://www.sciencedirect.com/science/article/pii/S0925443922000473},
	author = {Panagiotis M. Spatharas and Georgia I. Nasi and Paraskevi L. Tsiolaki and Marilena K. Theodoropoulou and Nikos C. Papandreou and Andreas Hoenger and Ioannis P. Trougakos and Vassiliki A. Iconomidou},
}